2014年7月17日星期四

Apoptosis |medchemexpress


The cells in the human body is doomed to death, some deaths are physical in nature, some deaths are pathological, research on cell death, has become a hot biology, medical research. People have been known to cell death are at least two ways, namely cell necrosis and apoptosis (apoptosis). Cell necrosis has long been recognized that a cell death, apoptosis and cell death is a way of gradually being recognized. 
Apoptosis is a fundamental biological phenomenon cells play essential roles in multicellular organisms eliminate unwanted or abnormal cells. It plays an important role in the evolution and development of the organism, and the environment within which the plurality of system stability. Apoptosis is not only a special type of cell death, but also has important biological significance and complexity of the molecular mechanisms. 
Apoptosis is a carefully controlled process of multiple genes. These genes are highly conserved between species, such as Bcl-2 family, caspase family of oncogenes such as C-myc, tumor suppressor gene P53, etc. With the development of molecular biology techniques for a variety of apoptotic process has considerable knowledge, but so far the exact mechanism of apoptosis is not fully understood. The disordered apoptosis may have a direct or indirect relationship with the occurrence of many diseases. Such as cancer, autoimmune diseases, can induce apoptosis of many factors, such as radiation, drugs. 
Part of the physical structure of a natural person apoptosis, such as human tail phase, the tail automatically apoptosis during development.
        the specialized technician from famous inhibitors supplier Medchemexpresschemicals will tell people main functions of this kind of inhibitors.you can find more information from it.
here are some information about medchemexpress.

Medchemexpress provides thousands of inhibitors, modulators and agonists with high purity and quality. They also have excellent customer reviews, precise and professional product citations, tech support and prompt delivery                             

Contact:
ADDRESS: 11 Deer Park Drive, Suite 102D Monmouth Junction, NJ 08852
TEL: 609-228-6898
FAX: 609-228-5909
E-mail:sales@medchemexpress.com
WEB:www.medchemexpress.com


Antibody-drug conjugates/ADCs Related |medchemexpress


Now, let the specialized technician from famous inhibitors supplier Medchemexpress chemicals will tell people main functions of this kind of inhibitors. 
Conjugation to cytotoxic drugs or radionuclides can expand the utility of mAbs and improve their potency and effectiveness, the antibodies are thus used as a means to target and delivery a toxic payload to the selected diseased tissue. This approach is currently a major focus of therapeutic research. Antibodies have been conjugated to a number of cytotoxic drugs, though various linker chemistries and these antibody drug conjugates (ADCs) have the ability to selectively and potently kill antigen–expressing tumor cells in vitro and in xenograft studies. ADCs have demonstrated success in the clinic, and there are now two such drugs, ado-trastuzumab emtansine (Kadcyla®) and brentuximab vedotin (Adcetris®), marketed in the United States. With over 30 ADCs currently undergoing clinical studies, it is likely that more conjugates will be approved in the future.
ADC development has been an iterative learning process, with ADCs evolving from murine antibodies that were conjugated to standard chemotherapeutic drugs to fully human antibodies conjugated to highly potent cytotoxic drugs. Our understanding of ADCs has improved substantially over the past 10 years and we now understand many of the critical factors required for their successful development, including target antigen selection, antibody, linker, and payload. One area of research that has seen recent advancement is that of conjugation chemistry. The implementation of site-specific conjugation, in which conjugation occurs only at engineered cysteine residues or unnatural amino acids for example, has resulted in homogeneous ADC production and improved ADC pharmacokinetic (PK) properties.
About Medchemexpress Chemicals
Medchemexpress provides thousands of inhibitors, modulators and agonists with high purity and quality. They also have excellent customer reviews, precise and professional product citations, tech support and prompt delivery                             

Contact:
ADDRESS: 11 Deer Park Drive, Suite 102D Monmouth Junction, NJ 08852
TEL: 609-228-6898
FAX: 609-228-5909
E-mail:sales@medchemexpress.com
WEB:www.medchemexpress.com



Anti-infection |medchemexpress


What is the main function of the cell signaling inhibitors? This should be a very professional problem. In a word, the professional problem needs to be solved by the professional people. Now, let the specialized technician from famous inhibitors supplier Medchemexpress chemicals will tell people main functions of this kind of inhibitors.today we will introduce you some information about Anti-infection.
Infection is the invasion of a host organism's bodily tissues by disease-causing organisms, their multiplication, and the reaction of host tissues to these organisms and the toxins they produce. Infectious diseases, also known as transmissible diseases or communicable diseases, comprise clinically evident illness (i.e., characteristic medical signs and/or symptoms of disease) resulting from the infection, presence and growth of pathogenic biological agents in an individual host organism. Infections are caused by infectious agents such as viruses, viroids, and prions, microorganisms such as bacteria, nematodes such as roundworms and pinworms, arthropods such as ticks, mites, fleas, and lice, fungi such as ringworm, and other macroparasites such as tapeworms.
Antiviral drugs are a class of medication used specifically for treating viral infections. Like antibiotics for bacteria, specific antivirals are used for specific viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development. Antiviral drugs are one class of antimicrobials, a larger group which also includes antibiotic (also termed antibacterial), antifungal and antiparasitic drugs. They are relatively harmless to the host, and therefore can be used to treat infections. They should be distinguished from viricides, which are not medication but deactivate or destroy virus particles, either inside or outside the body. Antivirals also can be found in essential oils of some herbs, such as eucalyptus oil and its constituents.

2014年7月9日星期三

PF-3084014

PF-3084014 is a novel gamma-secretase inhibitor that reduces amyloid-beta (Abeta) production with an in vitro IC(50) of 1.2 nM (whole-cell assay) to 6.2 nM (cell-free assay).
in vitro: The ability of PF-03084014 to inhibit gamma-secretase activity was shown by the reduction of endogenous NICD levels and by the downregulation of Notch target genes Hes-1 and c-Myc in the T-cell acute lymphoblastic leukemia (T-ALL) cell line HPB-ALL. PF-03084014 caused cell growth inhibition of several T-ALL cell lines via cell cycle arrest and induction of apoptosis [1]. PF-03084014 exhibited activity against tumor cell migration, endothelial cell tube formation, and mammosphere formation [3].
in vivo: Guinea pigs were dosed with PF-3084014 for 5 days via osmotic minipump at 0.03 to 3 mg/kg/day and exhibited dose-dependent reduction in brain, CSF, and plasma Abeta. To further characterize Abeta dynamics in brain, CSF, and plasma in relation to drug exposure and Notch-related toxicities, guinea pigs were dosed with 0.03 to 10 mg/kg PF-3084014, and tissues were collected at regular intervals from 0.75 to 30 h after dose. Brain, CSF, and plasma all exhibited dose-dependent reductions in Abeta, and the magnitude and duration of Abeta lowering exceeded those of the reductions in B-cell endpoints [2]. PF-03084014 treatment displayed significant antitumor activity in 10 of the 18 breast xenograft models. However, the antitumor efficacy in most models did not correlate with the in vitro antiproliferation results in the corresponding cell lines, suggesting the critical involvement of tumor microenvironment during Notch activation. In the tested breast xenograft models, the baseline expressions of the Notch receptors, ligands, and the cleaved Notch1 failed to predict the antitumor response to PF-03084014, whereas several Notch pathway target genes, including HEY2, HES4, and HES3, strongly corresponded with the response with a P value less than 0.01. Many of the best molecular predictors of response were also significantly modulated following PF-03084014 treatment  you can buy it from medchemexpress.

LY-411575

LY411575 is a potent γ-secretase inhibitor with IC50 of 0.078 nM/0.082 nM (membrane/cell-based), also inhibits Notch clevage with withIC50 of 0.39 nM.LY-411575 inhibits γ-secretase which can be assessed by the substrates like amyloid precursor protein (APP) and Notch S3 cleavage [1]. LY-411575, which blocks Notch activation, results in apoptosis in primary and immortalized KS cells [2].you  can  buy it from medchemexpress.

BMS-708163

BMS-708163 is a gamma-secretase inhibitor that is being developed for the treatment of Alzheimer's disease. Several LC-MS/MS methods have been developed for the determination of BMS-708163 in both plasma and cerebrospinal fluid in support of dog, rat, mouse and human studies. To support non-clinical studies, an LC-MS/MS method with a lower limit of quantitation (LLOQ) of 5 ng/mL, was developed and validated in dog, rat, and mouse plasma by using the deprotonated ion as the precursor ion. To support clinical studies, an LC-MS/MS method with LLOQ of 0.1 ng/mL, was developed and validated in human plasma by using the formate adduct as the precursor ion. Formic acid (0.01%) in water and acetonitrile was found to be the most favorable mobile phases for both deprotonated and formate adduct ions in negative electrospray ionization mode. A combination of a 3M Empore C18 plate for SPE and a Waters Atlantis dC18 analytical column for separation was used to achieve a highly selective solid phase extraction and chromatographic procedure from plasma without dry down and reconstitution steps. In the development of an assay for BMS-708163 in cerebral spinal fluid (CSF), significant non-specific binding of BMS-708163 was observed and resolved with pre- or post-spike of 0.2% Tween 20 into CSF samples. A dilute-and-shoot LC-MS/MS method with LLOQ of 0.1 ng/mL was developed and validated to assess BMS-708163 exposure in human CSF.
2 . Hartley RF, Huang Y, Cassidy M, Razler TM, Qian F, Hussain MA.Degradation kinetics and mechanism of an oxadiazole derivative, design of a stable drug product for BMS-708163, a γ-secretase inhibitor drug candidate.J Pharm Sci. 2012 Sep;101(9):3124-33
   you can it from medchemexpress,best price ,high quality inhibitors!

BMS 299897

BMS-299897 markedly reduced both brain and plasma Abeta in APP-YAC mice with ED(50) values of 86 and 22 mg/kg per os (po), respectively[1]. BMS 299897 is a selective inhibitor for gamma-secretase. Reductions in the formation of Abeta peptides by gamma-secretase inhibitors may be a viable therapy for reducing Abeta in Alzheimer's disease. BMS-299897 is a gamma-secretase inhibitor that was effective in reducing amyloid beta-peptide (A beta) in transgenic mice and guinea pigs[3]. in vitro: BMS-299897 dose-dependently increased brain concentrations of APP carboxy-terminal fragments, consistent with inhibition of gamma-secretase. BMS-299897 (100 mg/kg po) reduced brain and plasma Abeta(1-40) rapidly (within 20min) and maximally within 3 h. BMS-299897 dose-dependently reduced cortical, cerebrospinal fluid (CSF), and plasma Abeta in guinea pigs with ED(50) values of 30 mg/kg intraperitoneally, without affecting CSF levels of alpha-sAPP. The reductions in cortical Abeta correlated significantly with the reductions in both plasma (r(2) = 0.77) and CSF (r(2) = 0.61) Abeta [1]. in vivo: BMS-299897blocked the Aβ(25-35)-induced deficits in spontaneous alternation or novel object recognition, using a 1h intertrial time interval. BMS-299896 failed to affect the passive avoidance impairments or novel object recognition, using a 24h intertrial time interval [2]. Clinical trial: Study to Evaluate the Safety, Pharmacokinetics and Tolerability of BMS-299897 .Phage I.you can refer to more information at http://www.medchemexpress.com